CTD // Fund

Anlong Fund

Early & growth stage life sciences-focused VC firm investing primarily in China

Anlong Fund

china

Anlong Fund is an institutional investor (Conventional VCs) headquartered in Dongcheng, China. Anlong Fund is an early & growth stage venture capital investment company. Geographies of interest include China. Finances companies engaged in life sciences sectors such as Medical Devices, Biopharma & Biotech. Notable investments include Boast, Cinda Biopharmaceuticals, Biomarker Technologies. Notable portfolio companies: Boast, Cinda Biopharmaceuticals, Biomarker Technologies.

Stage: Growth, Growth
HQ: Dongcheng, china
Website: http://anlongmed.com

Institutional InvestorHealthcareHealthTechBiotechBiopharma

Related startups

Speediance

Speediance is a smart home gym equipment company that develops all-in-one AI-powered fitness machines enabling users to practice strength training,…

HealthTech · Shenzhen, China

Sleepace

Sleepace provides sleep tracking devices with companion mobile applications, offering products such as the Reston sleep monitoring device that tracks sleep…

HealthTech · Shenzhen, China

Galixir

Galixir is a biotechnology company that develops AI-based molecular drug discovery tools.

HealthTech · Beijing, China

📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.

⚠️ Common pitch mistakes we see →

Preparing to pitch Anlong Fund?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →